AIMM Therapeutics, Meibergdreef 59, 1105 BA Amsterdam Zuidoost, Netherlands; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 BA Amsterdam Zuidoost, Netherlands.
AIMM Therapeutics, Meibergdreef 59, 1105 BA Amsterdam Zuidoost, Netherlands.
J Immunol Methods. 2014 Aug;410:18-27. doi: 10.1016/j.jim.2014.06.010. Epub 2014 Jun 18.
Immunodeficient mice reconstituted with human hematopoietic stem cells provide a small-animal model for the study of development and function of human hematopoietic cells in vivo. However, in the current models, the immune response, and especially the humoral response by the human immune cells is far from optimal. The B cells found in these mice exhibit an immature and abnormal phenotype correlating with a reduced capacity to produce antigen-specific affinity matured antibodies upon infection or immunization. Herein, we review the current state of knowledge of development, function and antibody production of human B cells and discuss the obstacles for the improvement of these models.
免疫缺陷小鼠经人造血干细胞重建后,为研究人类造血细胞在体内的发育和功能提供了小动物模型。然而,在目前的模型中,人类免疫细胞的免疫反应,特别是体液免疫反应远非最佳。这些小鼠中发现的 B 细胞表现出不成熟和异常的表型,与感染或免疫后产生抗原特异性亲和力成熟抗体的能力降低有关。本文综述了人类 B 细胞发育、功能和抗体产生的最新知识,并讨论了改善这些模型的障碍。